How long do semaglutide side effects last ?
Simaglutide is a drug used to treat type 2 diabetes and obesity.
Common side effects of simaglutide include nausea, vomiting, diarrhea and other gastrointestinal symptoms, especially in the early stages or when the dose is increased. The duration and severity of side effects vary from person to person, and symptoms may last from a few days to a few weeks and improve over time or as the body adjusts to the medication.
Other side effects include decreased appetite, abdominal pain, and local reactions at the injection site. It is usually mild and disappears over time.

Liraglutide vs semaglutide
Differences:
1. Formula and Dosage:
Liraglutide is administered as a subcutaneous injection once day.
Cimarlutide is administered subcutaneously once a week or as an oral tablet daily.
2. Cimarlutide has higher potency and efficacy than larlutide. In clinical trials, it outperformed liraglutide in reducing HbA1c (a marker of long-term blood sugar control) and facilitating weight loss.
3. Weight Loss: Cimarlutide is approved to treat obesity alongside type 2 diabetes. Clinical trials have indicated that it is more effective than liraglutide for weight loss.
Tirzepatide vs semaglutide
Clinical trials have demonstrated that tisiparatide is extremely successful at lowering blood sugar levels and promoting weight loss in patients with type 2 diabetes and obesity. In terms of weight loss, it outperformed semaglutide.
Weight loss: In clinical trials, tixiparatide shown better weight reduction than simarutide.
Dose: Tisipartide is given once a week, whilst cimarutide is injected once a week or taken as a daily tablet.
How does semaglutide work ?
Semaglutide works by mimicking the incretin hormone naturally produced in the body.
Mechanism 1. Blood sugar regulation
(1) Stimulate insulin release:
On the one hand, semaglutide helps stimulate the pancreas to release insulin, which helps lower blood sugar levels by encouraging cells to absorb glucose for energy or storage.
(2) Inhibit glucagon release:
On the other hand, semaglutide also inhibits the release of glucagon, a hormone that raises blood sugar. By lowering glucagon levels, semaglutide helps prevent the liver from producing too much glucose.
Mechanism 2. Appetite regulation
Semaglutide slows the rate of gastric emptying, which can help reduce appetite and promote a feeling of fullness. This mechanism may result in reduced food intake.
Acts on the brain: GLP-1 receptors are also found in the brain, and by activating these receptors, semaglutide may help reduce appetite.
Mechanism 3. Effects on cardiovascular and renal
Semaglutide has been shown to have cardiovascular benefits, such as reducing the risk of heart attack, stroke and cardiovascular death in people with type 2 diabetes.
GLP-1 RAs may also have beneficial effects on the kidneys, including reducing the risk of progression of diabetic nephropathy.
Reference
[1].Jensen, M. D. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 129, S102–S138 (2014).
[2].Wadden, T. A. et al. STEP 3 Investigators. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA 325, 1403–1413 (2021).
